Treatment of Advanced Prostate Cancer: Where Are We in 2019?
In the last decade, important advances have been made in the treatment of metastatic prostate cancer, resulting in a better understanding of the biology underlying the disease, and in the approval of several therapeutic agents such as immunotherapy, new generation antiandrogens, cytotoxic chemothera...
Saved in:
| Main Authors: | Fernando Sabino Marques Monteiro, Andrey Soares, Fernando Nunes Galvão de Oliveira, Pedro Castilhos de Freitas Crivelaro, Pablo Moura Barrios, Andre Poisl Fay |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Thieme Revinter Publicações Ltda.
2019-01-01
|
| Series: | Brazilian Journal of Oncology |
| Subjects: | |
| Online Access: | http://www.thieme-connect.de/DOI/DOI?10.5935/2526-8732.20190001 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cambios en el valor del antígeno prostático específico en pacientes con COVID-19
by: Yildiray Yildiz, et al.
Published: (2025-07-01) -
Androgen receptor inhibitors in treating prostate cancer
by: Ryan N Cole, et al.
Published: (2025-03-01) -
New horizons for treating castration resistant prostate cancer: Bipolar Androgen Therapy
by: Pedro Henrique Isaacsson Velho, et al.
Published: (2018-04-01) -
Influence of obesity and androgen deficiency on prostatic blood circulation
by: I. A. Tyuzikov, et al.
Published: (2012-04-01) -
Divergent androgen regulation of unfolded protein response pathways drives prostate cancer
by: Xia Sheng, et al.
Published: (2015-04-01)